ATE446092T1 - Verwendung von oxycodon zur behandlung von viszeralem schmerz - Google Patents
Verwendung von oxycodon zur behandlung von viszeralem schmerzInfo
- Publication number
- ATE446092T1 ATE446092T1 AT06700652T AT06700652T ATE446092T1 AT E446092 T1 ATE446092 T1 AT E446092T1 AT 06700652 T AT06700652 T AT 06700652T AT 06700652 T AT06700652 T AT 06700652T AT E446092 T1 ATE446092 T1 AT E446092T1
- Authority
- AT
- Austria
- Prior art keywords
- oxycodone
- visceral pain
- treat visceral
- treat
- pain
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title 1
- 229960002085 oxycodone Drugs 0.000 title 1
- 208000009935 visceral pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64549005P | 2005-01-18 | 2005-01-18 | |
| PCT/EP2006/050252 WO2006077212A1 (en) | 2005-01-18 | 2006-01-17 | Use of oxycodone for treating visceral pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE446092T1 true ATE446092T1 (de) | 2009-11-15 |
Family
ID=35871217
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06700652T ATE446092T1 (de) | 2005-01-18 | 2006-01-17 | Verwendung von oxycodon zur behandlung von viszeralem schmerz |
| AT0014807U AT9895U1 (de) | 2005-01-18 | 2007-03-09 | Verfahren zur behandlung von viszeralem schmerz |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0014807U AT9895U1 (de) | 2005-01-18 | 2007-03-09 | Verfahren zur behandlung von viszeralem schmerz |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20080200493A1 (de) |
| EP (1) | EP1838318B1 (de) |
| JP (1) | JP5049139B2 (de) |
| KR (10) | KR20070100368A (de) |
| CN (1) | CN101106996B (de) |
| AP (1) | AP2249A (de) |
| AR (1) | AR052880A1 (de) |
| AT (2) | ATE446092T1 (de) |
| AU (1) | AU2006207498B2 (de) |
| BR (1) | BRPI0606247A2 (de) |
| CA (1) | CA2595043C (de) |
| CY (1) | CY1109660T1 (de) |
| DE (2) | DE202006019887U1 (de) |
| DK (2) | DK1838318T3 (de) |
| EA (1) | EA013544B1 (de) |
| ES (1) | ES2333901T3 (de) |
| HR (1) | HRP20090679T1 (de) |
| IL (1) | IL184530A (de) |
| ME (1) | ME01066B (de) |
| MX (1) | MX2007007207A (de) |
| MY (1) | MY144471A (de) |
| NO (1) | NO338968B1 (de) |
| NZ (1) | NZ555852A (de) |
| PL (1) | PL1838318T3 (de) |
| PT (1) | PT1838318E (de) |
| RS (1) | RS51069B (de) |
| SI (1) | SI1838318T1 (de) |
| TW (1) | TWI432196B (de) |
| UA (1) | UA85471C2 (de) |
| WO (1) | WO2006077212A1 (de) |
| ZA (1) | ZA200705231B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5123197B2 (ja) | 2005-11-14 | 2013-01-16 | ライナット ニューロサイエンス コーポレイション | カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体およびその使用方法 |
| NZ580972A (en) | 2007-06-04 | 2012-02-24 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
| JP5537441B2 (ja) | 2008-03-04 | 2014-07-02 | ファイザー・リミテッド | 慢性疼痛を治療する方法 |
| WO2010089132A1 (en) | 2009-02-06 | 2010-08-12 | Egalet A/S | Immediate release composition resistant to abuse by intake of alcohol |
| EP2445487A2 (de) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Retard-formulierungen |
| KR101519192B1 (ko) | 2009-08-28 | 2015-05-11 | 리나트 뉴로사이언스 코프. | 칼시토닌 유전자-관련된 펩티드에 대해 지시된 길항제 항체의 투여에 의한 내장 통증의 치료 방법 |
| CN103957935B (zh) | 2011-05-20 | 2018-04-03 | 奥尔德生物控股有限责任公司 | 抗cgrp或抗cgrp‑r抗体或抗体片段用于治疗或预防慢性和急性形式的腹泻的用途 |
| EP3662932B1 (de) | 2011-05-20 | 2021-04-07 | H. Lundbeck A/S | Anti-cgrp-zusammensetzungen und verwendung davon |
| NZ732970A (en) | 2011-05-20 | 2022-08-26 | H Lundbeck As | Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers |
| US20170114122A1 (en) | 2015-10-23 | 2017-04-27 | Alderbio Holdings Llc | Regulation of glucose metabolism using anti-cgrp antibodies |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| HRP20240159T1 (hr) | 2014-03-21 | 2024-04-12 | Teva Pharmaceuticals International Gmbh | Antagonistička protutijela usmjerena protiv peptida povezanog s genom kalcitonina i postupci koji ih koriste |
| KR20220031944A (ko) | 2016-09-23 | 2022-03-14 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 불응성 편두통의 치료 |
| BR112021006027A2 (pt) | 2018-11-19 | 2021-06-29 | Jazz Pharmaceuticals Ireland Limited | formulações de fármaco resistente a álcool |
| US11639380B2 (en) | 2019-01-08 | 2023-05-02 | H. Lundbeck A/S | Acute treatment and rapid treatment of headache using anti-CGRP antibodies |
| CA3077973A1 (en) | 2020-04-06 | 2021-10-06 | H. Lundbeck A/S | Treatment of most bothersome symptom (mbs) associated with migraine using anti-cgrp antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656295A (en) * | 1991-11-27 | 1997-08-12 | Euro-Celtique, S.A. | Controlled release oxycodone compositions |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| UA48219C2 (uk) * | 1996-03-25 | 2002-08-15 | Елі Ліллі Енд Компані | Композиція для вгамування болю (варіанти) та спосіб вгамування болю |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US6992193B2 (en) * | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
-
2006
- 2006-01-05 TW TW095100458A patent/TWI432196B/zh not_active IP Right Cessation
- 2006-01-09 MY MYPI20060082A patent/MY144471A/en unknown
- 2006-01-17 KR KR1020077018905A patent/KR20070100368A/ko not_active Ceased
- 2006-01-17 WO PCT/EP2006/050252 patent/WO2006077212A1/en not_active Ceased
- 2006-01-17 CN CN2006800024739A patent/CN101106996B/zh not_active Expired - Lifetime
- 2006-01-17 KR KR1020177004572A patent/KR20170021905A/ko not_active Ceased
- 2006-01-17 BR BRPI0606247-4A patent/BRPI0606247A2/pt not_active Application Discontinuation
- 2006-01-17 KR KR1020087029312A patent/KR20080106991A/ko not_active Ceased
- 2006-01-17 KR KR1020147018838A patent/KR20140091782A/ko not_active Ceased
- 2006-01-17 CA CA2595043A patent/CA2595043C/en not_active Expired - Lifetime
- 2006-01-17 EA EA200701541A patent/EA013544B1/ru not_active IP Right Cessation
- 2006-01-17 KR KR1020197035201A patent/KR20190135557A/ko not_active Ceased
- 2006-01-17 NZ NZ555852A patent/NZ555852A/en unknown
- 2006-01-17 MX MX2007007207A patent/MX2007007207A/es active IP Right Grant
- 2006-01-17 KR KR1020127011713A patent/KR20120089710A/ko not_active Ceased
- 2006-01-17 PL PL06700652T patent/PL1838318T3/pl unknown
- 2006-01-17 ES ES06700652T patent/ES2333901T3/es not_active Expired - Lifetime
- 2006-01-17 PT PT06700652T patent/PT1838318E/pt unknown
- 2006-01-17 KR KR1020207031796A patent/KR20200128451A/ko not_active Ceased
- 2006-01-17 KR KR1020227041445A patent/KR20220165797A/ko not_active Ceased
- 2006-01-17 UA UAA200708142A patent/UA85471C2/ru unknown
- 2006-01-17 KR KR1020237042001A patent/KR20230170811A/ko not_active Ceased
- 2006-01-17 EP EP06700652A patent/EP1838318B1/de not_active Expired - Lifetime
- 2006-01-17 DE DE202006019887U patent/DE202006019887U1/de not_active Expired - Lifetime
- 2006-01-17 DK DK06700652T patent/DK1838318T3/da active
- 2006-01-17 AP AP2007004057A patent/AP2249A/xx active
- 2006-01-17 RS RSP-2009/0553A patent/RS51069B/sr unknown
- 2006-01-17 DE DE602006009899T patent/DE602006009899D1/de not_active Expired - Lifetime
- 2006-01-17 AT AT06700652T patent/ATE446092T1/de active
- 2006-01-17 ME MEP-2009-352A patent/ME01066B/me unknown
- 2006-01-17 KR KR1020217034339A patent/KR20210131450A/ko not_active Ceased
- 2006-01-17 SI SI200630538T patent/SI1838318T1/sl unknown
- 2006-01-17 AU AU2006207498A patent/AU2006207498B2/en not_active Expired
- 2006-01-17 HR HR20090679T patent/HRP20090679T1/hr unknown
- 2006-01-17 JP JP2007550797A patent/JP5049139B2/ja not_active Expired - Fee Related
- 2006-01-17 US US11/814,020 patent/US20080200493A1/en not_active Abandoned
- 2006-01-18 AR ARP060100177A patent/AR052880A1/es unknown
-
2007
- 2007-03-09 AT AT0014807U patent/AT9895U1/de not_active IP Right Cessation
- 2007-07-02 ZA ZA200705231A patent/ZA200705231B/xx unknown
- 2007-07-10 IL IL184530A patent/IL184530A/en active IP Right Grant
- 2007-07-24 DK DK200700207U patent/DK200700207U3/da not_active IP Right Cessation
- 2007-08-14 NO NO20074174A patent/NO338968B1/no not_active IP Right Cessation
-
2009
- 2009-12-16 CY CY20091101308T patent/CY1109660T1/el unknown
-
2014
- 2014-10-15 US US14/515,216 patent/US9271974B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534379T1 (de) | Neue verwendung von peptid-verbindungen zur behandlung von muskelschmerzen | |
| EP1830876A4 (de) | Behandlung von hautmetastasen | |
| DE502006004066D1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| ATE446092T1 (de) | Verwendung von oxycodon zur behandlung von viszeralem schmerz | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| EP3871639C0 (de) | Vorrichtung zur behandlung von gastroösophagealer refluxkrankheit | |
| EP1744751A4 (de) | Verfahren zur behandlung von synucleinopathien | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| ATE521352T1 (de) | Verwendung von flibanserin zur behandlung von prämenopausalen störungen der sexuellen lust | |
| EP2135858A4 (de) | Zusammensetzung zur behandlung von infektionserkrankungen | |
| EP1838714A4 (de) | Verfahren zur behandlung von schmerzen | |
| EP2249765A4 (de) | Dapson zur behandlung von rosascea | |
| EP1924269A4 (de) | Vegetationswasser-zusammensetzung zur behandlung von entzündlichen hautkrankheiten | |
| EP1965827A4 (de) | Behandlung von entmyelinisierenden erkrankungen | |
| DE602007009877D1 (de) | Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen | |
| ZA200703531B (en) | Use of androgens to reduce the likelihood of acquiring or to treat skin aging | |
| ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
| ATE483460T1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
| ATE504307T1 (de) | Verwendung von gallium (iii) komplexen zur behandlung von melanomen | |
| DE502005003840D1 (de) | Anlage zur nichtinvasiven medizinischen behandlung | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| EP2403501A4 (de) | Pregnenolonsulfat zur behandlung von neurologischen erkrankungen | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1838318 Country of ref document: EP |